CSIMarket
 


Volitionrx Limited  (VNRX)
Other Ticker:  
 

Volitionrx Limited's Leverage Ratio

VNRX's quarterly Leverage Ratio and Total Liabilities, Equity growth


In III Quarter 2023 Volitionrx Limited had stockholder deficit.

Within In Vitro & In Vivo Diagnostic Substances industry Volitionrx Limited achieved the lowest Leverage Ratio in the third quarter 2023. While total ranking remained the same in the third quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are VNRX Customers?
What are VNRX´s Total Liabilities?


VNRX Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change - 25.47 % - - -86.69 %
Y / Y Total Liabilities Change -2.04 % 9.24 % -0.91 % 124.41 % 136.36 %
Leverage Ratio MRQ - 4.24 - - 7.22
VNRX's Total Ranking # # # # #
Seq. Equity Change - - - - -30.38 %
Seq. Total Liabilities Change -7.52 % 6.56 % -4.87 % 4.49 % 3.13 %



Leverage Ratio third quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Volitionrx Limited's Equity $ -3 Millions Visit VNRX's Balance sheet
Volitionrx Limited's Total Liabilities $ 20 Millions Visit VNRX's Balance sheet
Source of VNRX's Sales Visit VNRX's Sales by Geography


Cumulative Volitionrx Limited's Leverage Ratio

VNRX's Leverage Ratio for the trailling 12 Months

VNRX Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth - 25.47 % - - -86.69 %
Y / Y Total Liabilities TTM Growth -2.04 % 9.24 % -0.91 % 124.41 % 136.36 %
Leverage Ratio TTM - 45.42 101.36 5.64 1.99
Total Ranking TTM
Seq. Equity TTM Growth - - - - -30.38 %
Seq. Total Liabilities TTM Growth -7.52 % 6.56 % -4.87 % 4.49 % 3.13 %


On the trailing twelve months basis During the 12 months period ending III Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the In Vitro & In Vivo Diagnostic Substances industry VNRX recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are VNRX Customers?
What are VNRX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Sep 30 2023, within In Vitro & In Vivo Diagnostic Substances Industry Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Equity

Date modified: 2023-11-17T16:36:29+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com